Similar articles

• [Sublingual captopril: indications and advantages?].

  Meyer GJ. Meyer GJ. Dtsch Med Wochenschr. 2000 Apr 20;125 Suppl 1:S4. Dtsch Med Wochenschr. 2000. PMID: 10818992 German. No abstract available.
• [Clinical and hemodynamic evaluation of 6-week treatment of pulmonary hypertension in chronic obstructive lung diseases (COLD) with low dose of prazosin].

  Lewczuk J, Spikowski J, Sobkowicz-Woźniak B, Porada A, Wrabec K, Trzesicka M, Piszko P, Palka PS, Szczygielski J. Lewczuk J, et al. Kardiol Pol. 1990;33(6):358-64. Kardiol Pol. 1990. PMID: 2084301 Clinical Trial. Polish.
• [Advances in the drug therapy of pulmonary hypertension in patients with chronic obstructive pulmonary disease].

  Liu SZ, Chen WB. Liu SZ, et al. Zhonghua Jie He He Hu Xi Za Zhi. 1991 Apr;14(2):107-10. Zhonghua Jie He He Hu Xi Za Zhi. 1991. PMID: 1831694 Review. Chinese. No abstract available.
• [Management of hypertension in patients with cerebrovascular disease].

  Tsuchihashi T. Tsuchihashi T. Nihon Rinsho. 2004 Mar;62 Suppl 3:460-4. Nihon Rinsho. 2004. PMID: 15171416 Review. Japanese. No abstract available.
• Vasodilatory treatment of pulmonary hypertension.

  Widimský J. Widimský J. Eur J Respir Dis. 1986 Mar;68(3):161-6. Eur J Respir Dis. 1986. PMID: 2870937